Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

3.30
Delayed Data
As of 3:59pm ET
 +0.10 / +3.12%
Today’s Change
1.96
Today|||52-Week Range
4.55
+10.00%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close3.20
Today’s open3.20
Day’s range3.15 - 3.30
Volume881,281
Average volume (3 months)313,872
Market cap$104.9M
Dividend yield--
Data as of 3:59pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+32.42%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...-0.35-6.09%
ACRXAcelRx Pharmaceutica...-0.20-8.89%
MRTXMirati Therapeutics ...-0.30-7.41%
AGRXAgile Therapeutics I...+0.06+1.58%
Data as of 3:59pm ET, 06/27/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts